Abstract：Objective: To investigate the clinical application value of the molecular imaging SPECT/CT for bone metastases of breast cancer. Methods: Both MSCT and SPECT/CT imaging data of 68 suspicious bone metastases lesions of breast cancer were retrospectively analyzed and compared, and the statistics checkout was carried out. Resluts: Among the 55 bone metastases lesions of breast cancer, sensitivity, specificity and accuracy of bone metastases diagnosed by MSCT were 78.2％(43/55), 92.3%(12/13) and 80.9%(55/68); and sensitivity, specificity and accuracy of bone metastases diagnosed by SPECT/CT were 96.4％(53/55), 76.9%(10/13) and 92.6%(63/68). For the difference of the sensitivity and accuracy, there was statistically significance between MSCT and SPECT methods(P＜0.05), and the specificity of both methods was no difference. Conclusions: Comparing with MSCT, the SPECT/CT fusion imaging can improve the sensitivity and accuracy of the bone metastases diagnosis of breast cancer, and having better clinical application value.
董 科;傅健飞;楼菁菁;刘 江. 分子影像SPECT/CT对乳腺癌骨转移的临床应用价值[J]. , 2015, 26(7): 465-468.
DONG Ke;FU Jian-fei;LOU Jing-jing;LIU Jiang. The clinical application value of molecular imaging SPECT/CT for bone metastases from breast cancer. , 2015, 26(7): 465-468.
2015, Vol. 26 
